Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Panel
borderColor#ccc
bgColor#D8D8D8
titleBGColor#D0D0D0
borderStylesolid
titleTable of Contents
Table of Contents

...

Panel
borderColor#CCFFFF
bgColor#CCFFFF
titleBGColor#99FFFF
borderStylesolid

Rules Based on Patient's Age

  • If a patient is >= 19 years and did NOT complete the series before 19 years of age, then the Recommendation is Conditional and the reason code is HIGH_RISK.6
  • Shots administered to a patient who is >= 19 years and < 22 years of age will continue to be evaluated (based on minimum intervals) and, if valid, will count toward completion of the series.
  • If a patient's age at administration is >= 22 years and the patient did NOT complete the series before 22 years of age, then the Evaluation is Accepted and the reason code is ABOVE_REC_AGE_SERIES. (Shots administered to a patient >= 22 years of age do NOT count toward completion of the series; the series can NOT be completed once the patient is >= 22 years old.)

Series Completion Special Rule

  • Once a patient completes the MCV4 2-dose series the Recommendation is Not Recommended and the reason code is COMPLETE_HIGH_RISK.5 (Meningococcal should never have a recommendation of Not Recommended/Complete.)

...

Dose

Series Name

Absolute Minimum
 Age

Minimum Age

Routine
Age 

Latest Recommended Age (less than)Valid CVX Code(s) per Dose for this SeriesInvalid CVX Code(s) per Dose for this Series

1

 MCV4 2-dose

 10 years

11 years11 years13 years + 4 weeks114, 136, 108, 147, 32 N/A

2

 MCV4 2-dose

 16 years - 4 days 

16 years

16 years

17 years + 4 weeks 114, 136, 108, 147, 32 N/A

...

Doses

Series Name

Absolute Minimum Interval

Minimum Interval

Minimum Recommended Interval

Latest Recommended Interval (less than)

Dose 1 to 2

MCV4 2-dose

52 days

56 days

56 days2

6 years + 4 weeks


Panel
borderColor#CCFFFF
bgColor#CCFFFF
titleBGColor#99FFFF
borderStylesolid

Series Special Rules 

Shots Administered Below Series Recommended Age for Dose 1

  • If a shot of meningococcal is given below the series absolute minimum age (10 years), and above the CVX minimum age, then the Evaluation is accepted and the reason code is BELOW_REC_AGE_SERIES.3 Shots that are accepted do not count toward the series.

MCV4 2-Dose Series Exception Rule

  • If the patient is >= 16 years and < 19 years at time of execution and has no doses on record, then only 1 dose is indicated at >= 16 years; the series is complete after the single dose is administered at >= 16 years and < 19 years. 

...

Panel
borderColor#FDF5E6
bgColor#FDF5E6
titleBGColor#FAEBD7
borderStylesolid

Notes

  • The recommended interval between dose 1 and dose 2 in the table above (56 days)2 differs from the CDC CDSi recommended interval of 4 years. While the recommended intervals differ, in practice ICE and CDC CDSi will come up with the same recommended due date. CDC CDSi only uses the recommended interval when the recommended age is not provided. See the CDC CDSi Logic Specification for details on how they calculate their recommended due date.
  • Although shots administered below the series absolute minimum age are evaluated as Accepted3 rather than Invalid, the ICE general rule for Shots Administered Below Series Minimum Age for Dose 1 still applies. No minimum or recommended interval applies from the meningococcal shot given below the series absolute minimum age to target dose 1.
  • A shot of meningococcal administered below the series absolute minimum age should never be evaluated as Invalid/Below Minimum Age Series.